CyclophosphamideBone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsWhole-Body IrradiationBone and BonesHematopoietic Stem Cell TransplantationTransplantation ConditioningAnemia, AplasticLeukemiaCombined Modality TherapyBusulfanTransplantation ChimeraBone Marrow PurgingTreatment OutcomeGraft SurvivalHematopoietic Stem CellsLiver TransplantationBone Marrow DiseasesTissue DonorsHistocompatibility TestingHistocompatibilityRecurrenceHematopoiesisImmunosuppressive AgentsBone Marrow ExaminationTime FactorsTransplantation, IsogeneicMice, Inbred C57BLRemission InductionSurvival AnalysisLeukemia, Myeloid, AcuteLymphoma, Non-HodgkinBone Marrow NeoplasmsKidney TransplantationRadiation ChimeraDoxorubicinEtoposidePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveChemotherapy, AdjuvantDisease-Free SurvivalHematologic NeoplasmsImmunosuppressionSurvival RateLeukemia, MyeloidMethotrexateHepatic Veno-Occlusive DiseaseGraft RejectionColony-Forming Units AssayGranulocyte Colony-Stimulating FactorGraft vs Host ReactionAcute DiseaseStem Cell TransplantationCarmustineFollow-Up StudiesLymphocyte DepletionVincristineBone RemodelingCytarabineTransplantation ImmunologyAntineoplastic Agents, AlkylatingAntineoplastic AgentsT-LymphocytesMyelodysplastic SyndromesMelphalanHematologic DiseasesPrognosisActuarial AnalysisDrug Administration ScheduleLeukocyte TransfusionLeukocyte CountRetrospective StudiesChimeraSpleenHeart TransplantationCyclosporineHLA AntigensSevere Combined ImmunodeficiencyPrednisoneMultiple MyelomaLymphomaMice, Inbred BALB CCell DifferentiationPancytopeniaHodgkin DiseaseLymphocyte TransfusionFlow CytometryBone DensityLung TransplantationAntibodies, MonoclonalCells, CulturedAntigens, CD34Nuclear FamilyCisplatinThiotepa